Bristol Myers says actinium-225 therapy RYZ101 meets Phase 3 progression-free survival goal
The ACTION-1 interim analysis in neuroendocrine tumors after Lu-177 therapy disclosed no hazard ratio or medians; full data await a medical meeting.

Muse Wonder is on the Meta Model API and Muse Code; the Full model is subscription-only. Features include Active Memory and Active Focus.
The ACTION-1 interim analysis in neuroendocrine tumors after Lu-177 therapy disclosed no hazard ratio or medians; full data await a medical meeting.

GPT-6 Astra leads with 69.4 across eight tabletop tasks, but models took about 30 minutes per task versus 20 seconds for a person.

Hillclimb's 15 tasks are scored by private held-out verifiers; Claude Fable 5.1 leads at 1548 Elo ahead of GPT-6 Astra at 1232.
Ting-Wei Sun pleaded guilty in Manhattan federal court to four counts; prosecutors allege about $2.5 billion in AI hardware was shipped without licenses.
Interim Phase 1/2a data show effects lasting 90 days after the last dose; these are biomarker results, not Alzheimer's efficacy data.

It scores 86.9 against 83.2 for GPT-Live-1, though OpenAI keeps a narrow lead on τ-Voice; API price stays $0.08 a minute.

Microsoft projects 40% more tokens per megawatt than leading GPU systems; the figure is the company's own projection.
Available in Microsoft Foundry, it takes typed yes/no, choice and score questions; it joins OpenAI's Decisions API in the fast-decision niche.

The German company says it runs on five of its robot types; it published no benchmark scores and plans a live laundry demo at GTC Berlin.

Shown at the OCP Global Summit, the Crescent Island-based card is sampling; Intel has given no general availability date or price.
Results across 353 attempted Erdős problems and 492 OEIS conjectures are public in DeepMind's GitHub repository with machine-checked proofs.